Results 11 to 20 of about 98,565 (232)

Heme induces human and mouse platelet activation through C-type-lectin-like receptor-2 [PDF]

open access: yesHaematologica, 2020
Joshua H. Bourne   +8 more
doaj   +5 more sources

C-type lectin-like receptor (CLEC)-2, the ligand of podoplanin, induces morphological changes in podocytes

open access: yesScientific Reports, 2022
Podoplanin (PDPN) is intensely expressed on the podocyte membrane in an evolutionally conserved manner. CLEC-2, the endogenous ligand of PDPN, is highly expressed in platelets and also exists in a soluble form in plasma.
Keiko Tanaka   +6 more
doaj   +3 more sources

Expression of ADP receptor P2Y12, thromboxane A2 receptor and C-type lectin-like receptor 2 in cord blood-derived megakaryopoiesis

open access: yesPlatelets, 2021
The ADP receptor P2Y12, the thromboxane A2 receptor (TXA2R) and the C-type lectin-like receptor 2 (CLEC-2) mediate platelet activation by different mechanisms. Only little is known about the expression of the receptors in human megakaryopoiesis.
Catharina Gerhards   +6 more
doaj   +3 more sources

Identification of Podoplanin Aptamers by SELEX for Protein Detection and Inhibition of Platelet Aggregation Stimulated by C-Type Lectin-like Receptor 2 [PDF]

open access: yesBiosensors
Tumor cell-induced platelet aggregation (TCIPA) is a mechanism for the protection of tumor cells in the bloodstream and the promotion of tumor progression and metastases. The platelet C-type lectin-like receptor 2 (CLEC-2) can bind podoplanin (PDPN) on a
Hui-Ju Tsai   +6 more
doaj   +2 more sources

Soluble C-Type Lectin-Like Receptor 2 Is a Biomarker for Disseminated Intravascular Coagulation. [PDF]

open access: yesJ Clin Med, 2021
Disseminated intravascular coagulation (DIC) is induced by excess activation coagulation, and activated platelets are also involved in pathogenesis. Therefore, plasma levels of soluble C-type lectin-like receptor 2 (sCLEC-2), a new marker for platelet activation, can be expected as a marker of DIC in critically ill patients.
Yamamoto A   +11 more
europepmc   +4 more sources

Soluble C-Type Lectin-Like Receptor 2 Elevation in Patients with Acute Cerebral Infarction. [PDF]

open access: yesJ Clin Med, 2021
Background: Acute cerebral infarction (ACI) includes cardiogenic ACI treated with anticoagulants and atherosclerotic ACI treated with antiplatelet agents. The differential diagnosis between cardiogenic and atherosclerotic ACI is still difficult. Materials and Methods: The plasma sCLEC-2 and D-dimer levels were measured using the STACIA system. Results:
Nishigaki A   +14 more
europepmc   +4 more sources

Significant difference of c-type lectin-like receptor 2 between colorectal cancer and polyp subgroups. [PDF]

open access: yesCancer Biomark, 2021
BACKGROUND: Platelets play a key role in tumor progression and metastasis. C-type lectin-like receptor 2 (CLEC-2) is the receptor expressed on platelets and the marker of platelet activation. OBJECTIVE: This study aims to determine whether soluble CLEC-2 levels differ between patients with benign colorectal polyps and those with colorectal cancer (CRC).
Zhang ML   +6 more
europepmc   +3 more sources

Elevated Plasma Soluble C-Type Lectin-like Receptor 2 Is Associated with the Worsening of Coronavirus Disease 2019. [PDF]

open access: yesJ Clin Med, 2022
Although thrombosis in coronavirus disease 2019 (COVID-19) infection has attracted attention, the mechanism underlying its development remains unclear. The relationship between platelet activation and the severity of COVID-19 infection was compared with that involving other infections.
Wada H   +12 more
europepmc   +4 more sources

Decreased plasma level of C-type lectin-like receptor 2 (CLEC-2) in patients with breast cancer. [PDF]

open access: yesInt J Med Sci
Background: C-type lectin-like receptor 2 (CLEC-2) is involved in platelet activation, tumor metastasis, and vessel differentiation, but its role in breast cancer remains unclear. This study examined the association between clinical status and plasma levels of CLEC-2 in patients with breast cancer.
Chen CC   +10 more
europepmc   +3 more sources

Galectin‐9 activates platelet ITAM receptors glycoprotein VI and C‐type lectin‐like receptor‐2 [PDF]

open access: yesJournal of Thrombosis and Haemostasis, 2022
Platelets are multifunctional cellular mediators in many physiological and pathophysiological processes such as thrombosis, angiogenesis, and inflammation. Several members of galectins, a family of carbohydrate-binding proteins with a broad range of immunomodulatory actions, have been reported to activate platelets.In this study, we investigated the ...
Zhaogong Zhi   +11 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy